Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 143.26
0.944 %
$ 14.5 B
Market Cap
38.2
P/E
NBIX - CAPITAL EXPENDITURES
Capital Expenditures NBIX - Neurocrine Biosciences, Inc.
-28.3 M
LAST VALUE
-9.97%
2 YEAR CAGR
-2.67%
5 YEAR CAGR
-48.44%
10 YEAR CAGR